Literature DB >> 17266698

The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.

P Y Kim1, R J Stewart, S M Lipson, M E Nesheim.   

Abstract

BACKGROUND: Elevated plasma fibrinogen is a well known risk factor for cardiovascular disease. The mechanistic rationale for this is not known.
OBJECTIVES: These studies were carried out to determine the fibrinogen concentration dependencies of clotting and lysis times and thereby determine whether these times rationalize the correlation between an increased risk of cardiovascular disease and elevated plasma fibrinogen.
METHODS: The time courses of clot formation and lysis were measured by turbidity in systems comprising a) fibrinogen, thrombin and plasmin, or b) fibrinogen, thrombin, plasminogen and t-PA, or c) plasma, thrombin and t-PA. From the lysis times, k(cat) and K(m) values for plasmin action on fibrin were determined.
RESULTS: The time to clot increased linearly from 2.9 to 5.6 minutes as the fibrinogen concentration increased from 1 to 9 microM and did not increase further as the fibrinogen concentration was raised to 20 microM. In contrast, the clot lysis time increased linearly over the input fibrinogen concentration range of 2 to 20 microM. A similar linear trend was found in the two systems with t-PA and plasminogen. Apparent K(m) and k(cat) values for plasmin were 1.1 +/- 0.6 microM and 28 +/- 2 min(-1), respectively. K(m) values for plasmin in experiments initiated with t-PA and plasminogen were 1.6 +/- 0.2 microM in the purified system and 2.1 +/- 0.9 microM in plasma.
CONCLUSION: As the concentration of fibrinogen increases, especially above physiologic level, the balance between fibrinolysis and clotting shifts toward the latter, providing a rationale for the increased risk of cardiovascular disease associated with elevated fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266698     DOI: 10.1111/j.1538-7836.2007.02426.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  20 in total

1.  Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.

Authors:  Alexander Y Mitrophanov; Alisa S Wolberg; Jaques Reifman
Journal:  Mol Biosyst       Date:  2014-07-29

2.  Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.

Authors:  Paul Y Kim; Trang T Vu; Beverly A Leslie; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

3.  Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.

Authors:  D Green; C Chan; J Kang; K Liu; P Schreiner; N S Jenny; R P Tracy
Journal:  J Thromb Haemost       Date:  2009-12-15       Impact factor: 5.824

4.  The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.

Authors:  Colin Longstaff; Craig Thelwell; Stella C Williams; Marta M C G Silva; László Szabó; Krasimir Kolev
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

5.  High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population.

Authors:  Giuseppe De Luca; Monica Verdoia; Ettore Cassetti; Alon Schaffer; Chiara Cavallino; Virginia Bolzani; Paolo Marino
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

6.  Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men.

Authors:  Elissa H Wilker; Stacey E Alexeeff; Audrey Poon; Augusto A Litonjua; David Sparrow; Pantel S Vokonas; Murray A Mittleman; Joel Schwartz
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

7.  Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study.

Authors:  David Green; Nancy Foiles; Cheeling Chan; Pamela J Schreiner; Kiang Liu
Journal:  Atherosclerosis       Date:  2008-07-03       Impact factor: 5.162

8.  Gamma prime (γ') fibrinogen and carotid intima-media thickness: the Atherosclerosis Risk in Communities study.

Authors:  Pamela J Schreiner; Duke Appiah; Aaron R Folsom
Journal:  Blood Coagul Fibrinolysis       Date:  2017-12       Impact factor: 1.276

9.  Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Duke Appiah; Pamela J Schreiner; Richard F MacLehose; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-22       Impact factor: 8.311

10.  Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

Authors:  Kellie R Machlus; Jessica C Cardenas; Frank C Church; Alisa S Wolberg
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.